Mario Schlosser, director of Oscar Health, has sold a significant portion of his shares in the company. According to reports, Schlosser sold a total of 1.1 million shares in the company, netting him a substantial GBP 30.18m. The sale has raised questions about Schlosser's commitment to Oscar Health, with some speculating that it may be a sign of his intention to leave the company.
Oscar Health is a major player in the US health insurance market, and the company has been expanding its operations in recent years. The sale of Schlosser's shares may have implications for the company's future direction, particularly if he is no longer involved in the business.
The news of Schlosser's sale comes at a time when Oscar Health is facing increased competition in the US health insurance market. The company has been working to expand its operations and improve its services, but the sale of Schlosser's shares may be a sign of the challenges the company faces.
The sale of Schlosser's shares has been confirmed by Oscar Health, but the company has not commented on Schlosser's future involvement in the business. The news is likely to be closely watched by investors and analysts, who will be keen to see how the company responds to the sale.
In related news, Oscar Health is listed on the New York Stock Exchange (NYSE) and has a market capitalisation of over GBP 5bn. The company has a strong presence in the US health insurance market, and its services are available to millions of Americans.